Filing Details

Accession Number:
0001127602-12-008083
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-02-27 16:14:57
Reporting Period:
2012-02-24
Filing Date:
2012-02-27
Accepted Time:
2012-02-27 16:14:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1022079 Quest Diagnostics Inc DGX Services-Medical Laboratories (8071) 161387862
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1410233 Elizabeth Joan Miller C/O Quest Diagnostics Incorporated
3 Giralda Farms
Madison NJ 07940
Svp-Oncology & Neurology Srvcs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-02-24 2,895 $55.65 76,268 No 4 M Direct
Common Stock Acquisiton 2012-02-24 12,666 $56.82 88,934 No 4 M Direct
Common Stock Disposition 2012-02-24 15,561 $57.45 73,373 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2012-02-24 2,895 $0.00 2,895 $55.65
Common Stock Stock Options (Right to Buy) Disposition 2012-02-24 12,666 $0.00 12,666 $56.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,772 2020-02-10 No 4 M Direct
25,334 2021-02-15 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,047 Indirect 401(k)/SDCP
Footnotes
  1. 40,000 options granted on February 10, 2010 vest in equal annual installments beginning on the first annual anniversary of the grant date.
  2. 38,000 options granted on February 15, 2011 vest in equal annual installments beginning on the first annual anniversary of the grant date.
  3. The amount includes exempt purchases made under the Company's stock purchase plan.
  4. These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.